Sanofi Rightofuse Assets
Sanofi (SNY) had Rightofuse Assets of EUR 1.46 billion as of 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Notes
ifrs-full:RightofuseAssets · last filed 2026-02-17
- 2025-12-31: Rightofuse Assets 1.46B EUR.
- 2025-06-30: Rightofuse Assets 1.43B EUR.
- 2024-12-31: Rightofuse Assets 1.51B EUR.
- 2024-06-30: Rightofuse Assets 1.62B EUR.
| Period end | Rightofuse Assets |
|---|---|
| 2025-12-31 | 1.46B EUR 20-F · filed 2026-02-17 |
| 2025-06-30 | 1.43B EUR 6-K · filed 2025-10-27 |
| 2024-12-31 | 1.51B EUR 20-F · filed 2026-02-17 |
| 2024-06-30 | 1.62B EUR 6-K · filed 2024-07-25 |
| 2023-12-31 | 1.65B EUR 20-F · filed 2026-02-17 |
| 2023-06-30 | 1.72B EUR 6-K · filed 2023-07-28 |
| 2022-12-31 | 1.81B EUR 20-F · filed 2025-02-13 |
| 2022-06-30 | 1.88B EUR 6-K · filed 2022-07-28 |
| 2021-12-31 | 1.95B EUR 20-F · filed 2024-02-23 |
| 2021-06-30 | 1.47B EUR 6-K · filed 2021-07-29 |
| 2020-12-31 | 1.20B EUR 20-F · filed 2023-02-24 |
| 2020-06-30 | 1.24B EUR 6-K · filed 2020-07-29 |
| 2019-12-31 | 1.30B EUR 20-F · filed 2022-02-23 |
| 2019-01-01 | 1.43B EUR 20-F · filed 2021-03-04 |
| 2018-12-31 | 0.00 EUR 20-F · filed 2021-03-04 |
| 2017-12-31 | 0.00 EUR 20-F · filed 2020-03-05 |